ID
25306
Descrição
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Palavras-chave
Versões (7)
- 31/08/2017 31/08/2017 -
- 31/08/2017 31/08/2017 -
- 31/08/2017 31/08/2017 -
- 04/09/2017 04/09/2017 -
- 04/09/2017 04/09/2017 -
- 04/09/2017 04/09/2017 -
- 12/09/2017 12/09/2017 -
Transferido a
31 de agosto de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0018941 (UMLS CUI-2)
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])